SGO Issues October 3, 2013
SGO co-hosts Congressional briefing on ovarian cancer care
Annual Meeting abstract submissions top 900
Globe-athon to end women’s cancers held in more than 65 countries
Cancer Insurance Checklist now available for patients
SGO Appoints Education Manager
Bylaws amendment for review and vote
Gynecologic Oncology October 2013
At a Sept. 17 Congressional briefing hosted by the Society for Women’s Health Research (SWHR) in cooperation with the Society of Gynecologic Oncology (SGO) and Rep. Rosa DeLauro (D-CT), Clinical Practice Committee Chair Mitchell Edelson, MD, addressed more than 50 attendees with his presentation, “Ovarian Cancer: Improving Diagnosis, Transforming Care.”
Attendees included representatives of other organizations devoted to women’s and cancer issues, and staff representatives from the Women’s Caucus, Senate Aging, and House Energy and Commerce committees, as well as various individual Congressional offices.
Dr. Edelson discussed how, in a clinical setting, he works to detect ovarian cancer and deliver high quality care. He provided an in-depth look into ovarian cancer and the varying effects at each stage of the cancer, with measurement of reported symptoms and treatment along with survival rates at each stage. Dr. Edelson noted the importance of every woman having a team captain who is supported by a “Delivery Care Team.” He presented a concept from the SGO report, Creating a New Paradigm in Gynecologic Cancer Care: Policy Proposals for Delivery, Quality and Reimbursement, in which the team captain serves as the point person and the captain’s job is to coordinate the care for the patient. The delivery care team can include a physical therapist, pharmacist, oncology nurse, supportive care and survivorship care, serving as an essential support group that facilitates a patient’s transition through each stage of treatment.
Dr. Edelson also outlined the following potential solutions to optimize physician payment systems:
- Develop and test a diagnosis-based episode of care reimbursement system.
- Develop and test a diagnostic episode bundled payment system with an incentive for a team captain.
- Develop and test a bundled approach with no team captain.
- Develop and test a diagnosis-based episode bundled payments as a modified capitation payment system.
- Provide incentives for hospitals to become centers of excellence in gynecologic oncology.
“I think it is important for the SGO to inform members of Congress about our goal to elevate the care of women with ovarian cancer by defining measurable standards and ensuring early access to the best qualified health care providers,” said Dr. Edelson. “We are dedicated to working with leaders in health care policy in proposing and testing novel delivery care and reimbursement models.”
Also presenting at the briefing were Phyllis Greenberger, President and CEO of SWHR; Calaneet Balas, Chief Executive Officer of the Ovarian Cancer National Alliance; Elise C. Kohn, MD, Head of Gynecologic Cancer Therapies, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health; and Annie Ellis, who provided a patient perspective. Ellis, a public speaker and patient advocate, has been involved with the Ovarian Cancer National Alliance since 2006, including various committees, special projects and presentations with Survivors Teaching Students.
SGO received a total of 909 abstract and surgical film submissions for the 2014 Annual Meeting, with over 200 more submissions than last year. This year’s number of submissions is one of the highest in recent years; a total of 706 submissions were made for the 2013 Annual Meeting, with 746 entries for 2012 and 651 for 2011.
Abstracts were submitted in 18 categories, and this year there was a call for abstracts in five key concepts related to gynecologic oncology: Cancer Care Delivery System and Payment Reform; Cancer in Vulnerable Populations: Obesity, Elderly and the Underserved; Clinical Trials in Gynecologic Cancers: Phase I, II, III and Trials in Progress; Global Efforts to End Women’s Cancers; and Survivorship and Supportive Care. These key concepts accounted for 43 percent of the abstracts submitted.
The abstract submission breakdown was as follows:
|Disease site or treatment specific/translational research or basic science||514|
|Cancer in Vulnerable Populations: Obesity, Elderly and the Underserved||128|
|Cancer Care Delivery System and Payment Reform||73|
|Global Efforts to End Women’s Cancers||69|
|Survivorship and Supportive Care||60|
|Clinical Trials in Gynecologic Cancers: Phase I, II, III and Trials in Progress||59|
|TOTAL abstract submissions||909|
Abstracts will be graded during October and notifications of acceptance will be sent in November.
More than 65 countries participated in the first Globe-athon Walk to End Women’s Cancers the weekend of Sept. 28-29. As a grassroots movement fueled by social media, Globe-athon’s “Pass it On” video has already had more than 107,000 Facebook views.
Larry Maxwell, MD, FACOG, COL (ret.) U.S. Army, founder and director of Globe-athon, participated in the Globe-athon Walk around the White House on Sept. 29 and Robert L. Coleman, MD, SGO President-Elect II, took part in a Globe-athon event in Japan. The Globe-athon event in Madison, WI included David M. Kushner, MD, and Laurel W. Rice, MD, from the University of Wisconsin. Last month in Chicago, the SGO Board of Directors offered its support to the Globe-athon movement, which also promoted the National Race to End Women’s Cancer on Nov. 3 in Washington, DC.
In preparation for this month’s rollout of the Affordable Care Act, the Cancer Insurance Checklist has been developed to help individuals shop for insurance on their state’s Health Insurance Marketplace/Exchange if they have cancer, a history of cancer, or are at risk for cancer.
Practitioners can direct their patients to this checklist at www.cancerinsurancechecklist.org. From there patients can download this tool to compare insurance plans, compare costs, choose the plan that’s best for them and find additional resources.
This checklist was created through a partnership of The Assistance Fund, Association of Community Cancer Centers, Avalere Health, Cancer Support Community, Chronic Disease Fund, Cutaneous Lymphoma Foundation, International Myeloma Foundation, The Leukemia & Lymphoma Society, Living Beyond Breast Cancer, Lung Cancer Alliance, Melanoma Research Foundation, Men’s Health Network, National Coalition for Cancer Survivorship, Oncology Nursing Society, Ovarian Cancer National Alliance, Patient Advocate Foundation/National Patient Advocate Foundation, Patient Services, Inc., and the Prevent Cancer Foundation.
Kelly Hecklinger, MA, former adjunct English professor at University at Buffalo, has been named Senior Program Manager for Education at the Society of Gynecologic Oncology (SGO).
She brings knowledge and experience in educational development, implementation of instructional technology—including new mobile media—and conference management.
Fluent in Spanish and with an intermediate knowledge of Romanian, Hecklinger holds a master’s degree in English from the State University of New York at Buffalo and bachelor’s degree in Spanish form Arizona State University in Phoenix. As adjunct professor from 2008-2013, she developed learning objectives and expected outcomes for courses and enhanced the digital classroom experience through the innovative implementation of research databases, Internet and Microsoft Office suite tools.
“With her background in academia, Kelly offers SGO a fresh perspective on educational programs,” said SGO Executive Director Mary C. Eiken, MS, RN. “Her leadership will be critical as SGO retools its online learning and continues to build on the success of live education courses.”
Review the recommended addition to Article III Membership.
Renew your membership dues before Dec. 31.
The Oct. 15, 2013, deadline is approaching for two research grants through the SGO’s Foundation for Gynecologic Oncology: The Wilma Williams Education and Clinical Research Award for Endometrial Cancer, and the Improving Outcomes in Gynecologic Oncology Patients Research and Education Award. Winners will be notified by Dec. 2, 2013.
Lead Article: ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas
Editorial: Are ABCB1 (P-glycoprotein) polymorphisms clinically relevant in ovarian cancer? Finally an Answer! READ MORE